CMF-01630 | MCM6 | down-regulates | THRB | represses | R-438 | 6 | 2 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-02438 | IGF2BP1 | up-regulates | THRB | represses | R-438 | 6 | 1 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-15161 | YEATS2 | up-regulates | THRB | represses | R-438 | 6 | 1 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-19804 | CDH9 | up-regulates | THRB | represses | R-438 | 6 | 3 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-21702 | MUC17 | down-regulates | THRB | represses | R-438 | 6 | 2 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-30655 | SALL4 | up-regulates | THRB | represses | R-438 | 6 | 1 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-35057 | FGFR3 | down-regulates | hsa-mir-454-3p | represses | R-438 | 31 | 29 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-35089 | FGFR3 | down-regulates | hsa-mir-20b | represses | R-438 | 44 | 26 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-35195 | SCNN1G | up-regulates | hsa-mir-106b | represses | R-438 | 21 | 13 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-35977 | AHNAK2 | up-regulates | hsa-mir-106b | represses | R-438 | 21 | 16 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-36000 | AHNAK2 | up-regulates | hsa-mir-93 | represses | R-438 | 44 | 26 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-36028 | AHNAK2 | up-regulates | hsa-mir-20b | represses | R-438 | 44 | 26 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-36161 | TNK2 | up-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 40 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-36695 | ATP8A2 | up-regulates | hsa-mir-454-3p | represses | R-438 | 31 | 27 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-36737 | ATP8A2 | up-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 40 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-36766 | ATP8A2 | up-regulates | hsa-mir-93 | represses | R-438 | 44 | 32 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-36800 | ATP8A2 | up-regulates | hsa-mir-20b | represses | R-438 | 44 | 31 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-37377 | SLCO6A1 | up-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 3 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-37704 | ADAMTS8 | up-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 40 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-38091 | OR51F1 | up-regulates | hsa-mir-106b | represses | R-438 | 21 | 17 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-38113 | OR51F1 | up-regulates | hsa-mir-93 | represses | R-438 | 44 | 35 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-38327 | ZNF845 | up-regulates | hsa-mir-454-3p | represses | R-438 | 31 | 27 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-38429 | KCNB2 | down-regulates | hsa-mir-106b | represses | R-438 | 21 | 15 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-38457 | KCNB2 | down-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 36 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-38484 | KCNB2 | down-regulates | hsa-mir-93 | represses | R-438 | 44 | 27 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-38574 | CPNE8 | down-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 28 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-38594 | CPNE8 | down-regulates | hsa-mir-93 | represses | R-438 | 44 | 20 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-38992 | SGIP1 | down-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 26 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39016 | SGIP1 | down-regulates | hsa-mir-93 | represses | R-438 | 44 | 23 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39039 | SGIP1 | down-regulates | hsa-mir-20b | represses | R-438 | 44 | 23 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39147 | DNMBP | down-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 35 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39563 | NF1 | down-regulates | hsa-mir-106b | represses | R-438 | 21 | 20 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39633 | NF1 | down-regulates | hsa-mir-93 | represses | R-438 | 44 | 31 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39724 | NF1 | down-regulates | hsa-mir-20b | represses | R-438 | 44 | 31 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39779 | RPSAP58 | down-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 40 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39831 | UGT2B4 | down-regulates | hsa-mir-149 | represses | R-438 | 51 | 35 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39935 | TDRD9 | down-regulates | hsa-mir-106b | represses | R-438 | 21 | 21 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-39971 | TDRD9 | down-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 42 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-40138 | STAB2 | up-regulates | hsa-mir-106b | represses | R-438 | 21 | 8 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-41346 | TP53 | up-regulates | hsa-mir-17-3p | represses | R-438 | 52 | 52 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-41388 | TP53 | up-regulates | hsa-mir-93 | represses | R-438 | 44 | 44 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-41550 | TP53 | up-regulates | hsa-mir-20b | represses | R-438 | 44 | 44 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-41779 | IQSEC3 | up-regulates | hsa-mir-454-3p | represses | R-438 | 31 | 25 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |
CMF-41911 | IQSEC3 | up-regulates | hsa-mir-20b | represses | R-438 | 44 | 34 | Drugs (27) Regulator Drugs (3)RESMETIROM, MB07811, EPROTIROME Regulon Drugs (24)LY-2787106, PICOTAMIDE, FIBOFLAPON SODIUM, ATN-161, TERBOGREL, L19IL2, AS-1409, L19TNFA, MUPARFOSTAT, PREXIGEBERSEN, L19SIP 131I, PF-04605412, OTLERTUZUMAB, BI-836826, ERITORAN TETRASODIUM, VELIFLAPON, OCRIPLASMIN, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, OZAGREL, VESENCUMAB, NARATUXIMAB EMTANSINE, FIBOFLAPON |